Evidence map›Paper›PMID 22432009›Full record

ArticlePloS one2012

ER stress in retinal degeneration in S334ter Rho rats.

Vishal M Shinde, Olga S Sizova, Jonathan H Lin, Matthew M LaVail, Marina S Gorbatyuk

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Gene Therapy for Rhodopsin Mutations.Cold Spring Harbor perspectives in medicine · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Loss of the cone-enrichedMolecular vision · 2017
    Article
  17. Article
  18. Review
  19. Article
  20. Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses.Investigative ophthalmology & visual science · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Vishal M ShindeDepartment of Cell Biology and Anatomy, University of North Texas Health Science Center, North Texas Eye Research Institute, Fort Worth, Texas, United States of America.
Olga S Sizova
Jonathan H Lin
Matthew M LaVail
Marina S Gorbatyuk
University of North Texas · USUniversity of California, San Francisco · USUniversity of North Texas Health Science Center · USUniversity of San Diego · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAMBA, DEEPAK ASHOK · 1985 to 2024
$16.8M
CELLULAR MECHANISMS OF INHERITED RETINAL DEGENERATIONR01EY001919 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1985 to 2014
$8.3M
RODENT MODELS OF RETINAL DEGENERATIONR01EY006842 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1992 to 2014
$3.6M
Endoplasmic Reticulum Stress in Retinal DegenerationR01EY020846 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIN, JONATHAN · 2010 to 2014
$1.9M
Unfolded Protein Response as a Therapeutic Target for ADRP Animal ModelsR01EY020905 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI GORBATYUK, MARINA · 2010 to 2014
$1.3M
Endoplasmic Reticulum Stress in Retinal DegenerationK08EY018313 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIN, JONATHAN · 2007 to 2011
$920k
BREEDING COLONY WITH INHERITED RETINAL DYSTROPHYU01EY006842 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1986 to 1992
–
CELLULAR MECHANISMS OF INHERITED RETINAL DEGENERATIONR37EY001919 · NEI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LAVAIL, MATTHEW M · 1989 to 1998
–
NEUROPHYSIOLOGY OF INTERMEDIATE LEVEL VISIONF32EY006842 · NEI · ROCKEFELLER UNIVERSITY · PI BAKIN, JONATHAN S · 1997 to 1999
–
NEI NIH HHS 1 RO1 EY020905-1NEI NIH HHS EY001919NEI NIH HHS EY002162NEI NIH HHS EY006842NEI NIH HHS EY018313NEI NIH HHS EY020846NEI NIH HHS F32 EY006842NEI NIH HHS K08 EY018313NEI NIH HHS P30 EY002162NEI NIH HHS R01 EY001919NEI NIH HHS R01 EY006842NEI NIH HHS R01 EY020846NEI NIH HHS R01 EY020905
6 · The paper itself

Abstract

The S334ter rhodopsin (Rho) rat (line 4) bears the rhodopsin gene with an early termination codon at residue 334 that is a model for several such mutations found in human patients with autosomal dominant retinitis pigmentosa (ADRP). The Unfolded Protein Response (UPR) is implicated in the pathophysiology of several retinal disorders including ADRP in P23H Rho rats. The aim of this study was to examine the onset of UPR gene expression in S334ter Rho retinas to determine if UPR is activated in ADRP animal models and to investigate how the activation of UPR molecules leads to the final demise of S334ter Rho photoreceptors. RT-PCR was performed to evaluate the gene expression profiles for the P10, P12, P15, and P21 stages of the development and progression of ADRP in S334ter Rho photoreceptors. We determined that during the P12-P15 period, ER stress-related genes are strongly upregulated in transgenic retinas, resulting in the activation of the UPR that was confirmed using western blot analysis and RT-PCR. The activation of UPR was associated with the increased expression of JNK, Bik, Bim, Bid, Noxa, and Puma genes and cleavage of caspase-12 that together with activated calpains presumably compromise the integrity of the mitochondrial MPTP, leading to the release of pro-apoptotic AIF1 into the cytosol of S334ter Rho photoreceptor cells. Therefore, two major cross-talking pathways, the UPR and mitochondrial MPTP occur in S334ter-4 Rho retina concomitantly and eventually promote the death of the photoreceptor cells.

Indexed as

Endoplasmic Reticulum StressAgingAnimalsApoptosisApoptotic Protease-Activating Factor 1AutophagyBiomarkersCalpainEndoplasmic Reticulum-Associated DegradationExtracellular Signal-Regulated MAP KinasesEye ProteinsGene Expression RegulationHumansJNK Mitogen-Activated Protein KinasesMitochondriaMutationApaf1 protein, ratApoptotic Protease-Activating Factor 1BiomarkersCalpainExtracellular Signal-Regulated MAP KinasesEye ProteinsJNK Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, ratRhodopsinTranscription Factors

Identifiers

PMID22432009
PMCPMC3303830
OpenAlexW2000627282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.